Researchers have found that though follicular lymphoma expresses BCL-2 at high levels, its response to venetoclax is quite low (77) This result contradicts the viewpoint that BCL-2 protein expression and resistance to venetoclax are negatively correlated. The gene discussed is BCL2; the disease is follicular lymphoma.